I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with extensive experience in research and development, as well as a deep understanding of technological innovation in the industry. Today, we’re diving into the groundbreaking news about AstraZeneca’s Imfinzi and Imjudo
What if a single drug could redefine survival chances for thousands facing lung cancer surgery in Europe? Imagine a patient, newly diagnosed with non-small cell lung cancer (NSCLC), grappling with the uncertainty of whether their tumor can be removed and if they’ll face recurrence. For many, this
Imagine a world where a solution to one of the deadliest cancers among men lies hidden beneath the ocean's surface, offering hope to those battling prostate cancer. This disease, claiming over 375,000 lives globally each year, often evolves into drug-resistant forms that defy conventional
I'm thrilled to sit down with Ivan Kairatov, a leading biopharma expert with extensive experience in research and development, particularly in the intersection of technology and innovation in the industry. Today, we’re diving into groundbreaking insights on how T cells, crucial players in our
In a world where gastrointestinal (GI) cancers continue to pose a formidable challenge to global health, a groundbreaking study from researchers at Weill Cornell Medicine-Qatar has unveiled a potential game-changer in cancer therapy. GI cancers, encompassing colorectal, stomach, liver, esophageal,
In a remarkable stride forward for cancer diagnostics, a cutting-edge whole-body MRI technique is offering new hope to those battling myeloma, a challenging form of blood cancer, through the collaborative efforts of researchers at The Royal Marsden NHS Foundation Trust and The Institute of Cancer
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39